Reply to the Editor—From AFFIRM to EAST—Better rhythm control and general AF management explain differences in outcomes

Volume: 18, Issue: 10, Pages: 1814 - 1814
Published: Oct 1, 2021
Abstract
The EAST-AFNET 4 trial showed clinical benefit of systematic, early initiation of rhythm control therapy in patients with AF, with 21% fewer cardiovascular events compared to rhythm control given only to symptomatic patients. 1 Kirchhof P. Camm A.J. Goette A. et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020; 383: 1305-1316 Crossref PubMed Scopus (313) Google Scholar Patients with recently diagnosed AF...
Paper Details
Title
Reply to the Editor—From AFFIRM to EAST—Better rhythm control and general AF management explain differences in outcomes
Published Date
Oct 1, 2021
Volume
18
Issue
10
Pages
1814 - 1814
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.